Earnings And Financial PerformanceThe company reported non-GAAP EPS of $0.96, up 14% year over year, driven by operating leverage following the company’s internal investments.
Product Launch And AdoptionThe broader release of MyDay now that it is no longer supply constrained and MiSight adoption from the longer trials could drive upside to Q4.
Stock ValuationA perceived gap between the company's valuation and its strong fundamentals presents an attractive opportunity for investors.